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Abstract
The replication of porcine endogenous retrovirus (PERV) in human cell lines suggests a potential
infectious risk in xenotransplantation. PERV isolated from human cells following cocultivation with
porcine peripheral blood mononuclear cells is a recombinant of PERV-A and PERV-C. We describe
two different recombinant PERV-AC sequences in the cellular DNA of some transmitting miniature
swine. This is the first evidence of PERV-AC recombinant virus in porcine genomic DNA that may
have resulted from autoinfection following exogenous viral recombination. Infectious risk in
xenotransplantation will be defined by the activity of PERV loci in vivo.
Background
Xenotransplantation using inbred miniature swine is a
proposed solution to the shortage of organs available for
transplantation. Three subgroups of porcine endogenous
retroviruses (PERV) have been identified, PERV-A, -B, and
-C. PERV-A and PERV-B have been shown to replicate in
human cells in vitro, while PERV-C is largely restricted to
porcine cells [1-5]. Infection of human subjects has not
been identified in individuals with exposure to porcine
tissue [3,6-9], though concern about the risk of cross-spe-
cies infection in xenotransplantation still exists.
It has been demonstrated that PERV replicating efficiently
in human cells in vitro is a recombinant of PERV-A and -
C within the env region, and probably arises from exoge-
nous recombination of mRNA [2,5,10]. Following cocul-
tivation of "transmitting" porcine peripheral blood
mononuclear cells (PBMC) with human cell lines, PERV-
AC recombinants have been identified within human cells
in vitro [2,4,5]. PERV-AC recombinant provirus has not
been detected previously in the genomes of transmitting
swine [5,10].
To examine the mechanisms underlying PERV recombina-
tion, four animals not known to transmit recombinant
virus to human cells in vitro and four animals previously
characterized as having a transmitting phenotype were
identified from a herd of inbred miniature swine [5,11].
Polymerase chain reaction (PCR) assays of tissue samples
and coculture studies between porcine and human cells
were undertaken to better characterize recombinant PERV
in vivo.
Results
Using VRBF and TMR PCR primers, PERV-AC recom-
binant virus was detected in the cellular DNA isolated
from all four transmitting animals, 13910, 15149, 13653,
and 15150 (Fig. 1). Each PCR was repeated at least three
different times. Lung, heart, thymus, PBMC, abdominal
and thoracic lymph nodes, spleen, liver, and kidney from
animals 13910 and 15149 contained recombinant virus.
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Pancreatic tissue did not contain virus. Only PBMC were
available for testing from animals 13653 and 15150.
Sequencing performed in duplicate on samples from ani-
mals 13910 and 15149 revealed 98% homology with a
previously published PERV-AC sequence from infected
human cells lines, AY364236.1(Fig. 2 and 3) [10]. Sam-
ples from animals 13653 and 15150 showed closer
homology to another PERV-AC clone, AF417230(Fig. 2
and 3) [2].
Comparison of sequences from 13653 and 15150
revealed a 0.2% difference (3 out of 1284 base pairs).
Comparison of sequences from 3 different tissues (spleen,
liver, and PBMC in 13910 and spleen and PBMC in
15149) showed a difference of 0.4 – 1.2%. Some of these
minute differences within multiple samples of the same
tissues are within the realm of PCR and sequencing arti-
fact, though the presence of actual small variations cannot
be ruled out. Non-transmitting swine 15578, 15579,
16181, and 12190 revealed no evidence of genomic DNA
PERV-AC recombinant virus in lymph node, liver, spleen,
lung, thymus, or PBMC (animals 15578 and 15579) or
just PBMC (12190).
Using primer pair VRBF and PERV-C reverse, a second
PERV-AC recombinant was detected in the DNA of 13910
Gel electrophoresis from PCR of genomic DNA from multiple samples Figure 1
Gel electrophoresis from PCR of genomic DNA from multiple samples. Lane M represents the lane marker. Samples are as fol-
lows: 1, 15149; 2, 13910; 3, 13653; 4, 15150; 5, 15578; 6, 15579; 7, 12910; 8, 16181; 9, A14-220; and 10, water. The A14-220 
DNA serves as a positive control for PCR involving recombinant PERV-AC, the water as a negative control. Bands seen with 
primer pairs VRBF and TMR are between the 1000 and 1650 base pair lane markers. Bands seen with primer pairs VRBF and 
C-reverse are between the 300 and 400 base pair lane markers.
         M       1       2       3       4       5       6       7       8       9      10
Primer pair VRBF and TMR 
 M      1       2        3       4        5       6       7       8      9     10 
Primer pair VRBF and C-reverse 
         M      1        2        3       4        5        6        7        8        10 
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and 15149 in all tissues tested, again with the exception of
pancreas (Fig. 1). Sequencing of amplified product from
PBMC of both subjects demonstrated identical 345 base
pair sequences (Fig. 4). The first 254 bases had 99%
homology to a sequence from the SU region of a previ-
ously published PERV-A clone DD8a8 env gene [2]. The
remaining 91 base pairs shared 98% homology to 6 differ-
ent previously published PERV-C env genes (AY570980,
AF417227,  AF402662,  AF402661,  AF038600, and
AF038599). This same primer pair revealed no evidence
of recombinant virus within the isolated DNA of cells
from lymph node, liver, lung, thymus, spleen, and PBMC
from swine 15578 and 15579. Only PBMC were available
for testing in animals 16181 and 12190.
Discussion
These studies demonstrate the presence of recombinant
PERV-AC in the DNA of four different transmitting swine.
It is unclear whether the "transmitting" phenotype is a sta-
ble or intermittent trait and whether genomic PERV-AC
sites are active. Wood et al. detected PERV-AC viral mRNA
in unstimulated PBMC of transmitting animals; the
sequences of these PERV recombinants were not com-
pared with those derived from infected human cells [5].
While the possibility exists that blood-derived elements
account for the provirus we have detected in multiple tis-
sues, previous studies did not demonstrate PERV-AC from
PBMC of limited numbers of transmitting animals [5,10].
Multiple PERV-AC recombinants have been described
after in vitro infection of human cells. Episodic viral
recombination might lead to the development of multiple
strains of PERV-AC in a single animal, with autoinfection
and with variable integration into cellular DNA of differ-
ent tissues. The absence of virus from a single tissue (pan-
creas) in a transmitting animal with genomic PERV-AC is
consistent with this hypothesis. However, enzymatic deg-
radation of cellular DNA and RNA in pancreatic tissue or
other factors might limit detection of PERV-AC in this
organ. Of note, though, smaller fragments of control DNA
from the cellular DNA harvested from pancreatic samples
were still amplifiable by PCR (data not shown). The pres-
ence of two different types of PERV-AC in the cellular
DNA of some transmitting animals suggests, however,
that PERV recombination is intermittent and leaves
behind genomic evidence of autoinfectious cycles.
Diagram illustration of the PERV-AC envelope generated by primer pair VRBF and TMR from animals 13910, 15149, 13653,  and 15150, compared to envelopes from PERV-A (clear) and PERV-C (shaded) Figure 2
Diagram illustration of the PERV-AC envelope generated by primer pair VRBF and TMR from animals 13910, 15149, 13653, 
and 15150, compared to envelopes from PERV-A (clear) and PERV-C (shaded).
PERV-A env
PERV-C env
PERV-AC env (13910 and 15149)
PERV-AC env (13653 and 15150)
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Deduced PERV-AC amino acid sequences from all four transmitters are shown in alignment with a PERV-A and PERV-C env  sequences Figure 3
Deduced PERV-AC amino acid sequences from all four transmitters are shown in alignment with a PERV-A and PERV-C env 
sequences. Amino acid 279 from PERV-C, 297 from PERV-A, 296 from subjects 13910 and 15149, and 297 from subjects 
13653 and 15150, represent the start of the TM region of the env. Blue amino acids represent PERV-A and red amino acids 
represent PERV-C. The sequences encoded by the forward PERV-A primer (VRBF) and reverse PERV-C primer (TMR) are 
underlined.
PERV-C YTSSGQFNY- ---------- -LTWIRTGSP KCSPSDLDYL KISFTEKGKQ 38
PERV-A PTSYNQFNYG HGRWKDWQQR VQKDVRNKQI SCHSLDLDYL KISFTEKGKQ 50
13910 PTSYNQFNYG HGRWKDWQQR VQKDVRNKQI SCHSLDLDYL KISFTEKGKQ 50
15149 PTSYNQFNYG HGRWKDWQQR VQKDVRNKQI SCHSLDLDYL KISFTEKGKQ 49
13653 PTSYNQFNYG HGRWKDWQQR VQKD-RNKQI SCHSLDLDYL KISFTEKGKQ 50
15150 PTSYNQFNYG HGRWKDWQQR VQKDVRNKQI SCHSLDLDYL KISFTEKGKQ 50
 PERV-C ENILKWVNGM SWGMVYYGGS GKQPGSILTI RLKIN-QLEP PMAIGPNTVL 87
PERV-A ENIQKWVNGI SWGIVYYGGS GRKKGSVLTI RLRIETQMEP PVAIGPNKGL 100
13910 ENIQKWVNGM SWGIVYYGGS GRKKGSVLTI RLRIETQMEP PVAIGPNKGL 100
 15149 ENIQKWVNGM SWGIVYYGGS GRKKGSVLTI RLRIETQMEP PVAIGPNKGL 99
13653 ENIQKWVNGM SWGIVYYGGS GRKKGSVLTI RLRIETQMEP PVAIGPNEGL 100
15150 ENIQKWVNGM SWGIVYYGGS GRKKGSVLTI RLRIETQMEP PVAIGPNKGL 100
PERV-C TGQRPPTQ-- --GPGPS-SN ITSGSDPTES SSTTKMGAKL FSLIQGAFQA 132
PERV-A AEQGPPIQEQ RPSPNPSDYN TTSGSVPTEP NITIKTGAKL FSLIQGAFQA 150
13910   AEQGPPIQEQ RPSPNPSDYN TTSGSVPTEP NITIKTGAKL FNLIQGAFQA 150
15149 AKQGPPIQEQ RPSPNPSDYN TTSGSVPTEP NITIKTGAKL FNLIQGAFQA 149
13653 AEQGPPIQEQ RPSPNPSDYN TTSGSVPTEP NITIKTGAKL FNLIQGAFQA 150
15150 AEQGPPIQEQ RPSPNPSDYN TTSGSVPTEP NITIKTGAKL FNLIQGAFQA 150
PERV-C LNSTTPEATS SCWLCLASGP PYYEGMARRG KFNVTKEHRD QCTWGSQNKL 182
PERV-A LNSTTPEATS SCWLCLASGP PYYEGMARGG KFNVTKEHRD QCTWGSQNKL 200
13910   LNSTTPEATS SCWLCLASGP PYYEGMARGG KFNVTKEHRD QCTWGSQNKL 200
15149 LNSTTPEATS SCWLCLASGP PYYEGMARGG KFNVTKEHRD QCTWGSQNKL 199
13653 LNSTTPEATS SCWLCLASGP PYYEGMARGG KFNVTKEHRD QCAWGSQNKL 200
15150 LNSTTPEATS SCWLCLASGP PYYEGMARGG KFNVTKEHRD QCAWGSQNKL 200
PERV-C TLTEVSGKGT CIGKVPPSHQ HLCNHTEAFN QTSESQYLVP GYDRWWACNT 232
PERV-A TLTEVSGKGT CIGMVPPSHQ HLCNHTEAFN RTSESQYLVP GYDRWWACNT 250
13910   TLTEVSGKGT CIGMVPPSHQ HLCNHTEAFN RTSESQYLVP GYDRWWACNT 249
15149 TLTEVSGKGT CIGKVPPSHQ HLCNHTEAFN RTSESQYLVP GYDRWWACNT 249
13653 TLTEVSGKGT CIGKVPPSHQ HLCNHTEAFN QTSESQYLVP GYDRWWACNT 250
15150 TLTEVSGKGT CIGKVPPSHQ HLCNHTEAFN QTSESQYLVP GYDRWWACNT 250
PERV-C GLTPCVSTLV FNQTKDFCIM VQIVPRVYYY PEKAILDEYD YRNHRQKREP 282
PERV-A GLTPCVSTLV FNQTKDFCVM VQIVPRVYYY PEKAVLDEYD YRYNRPKREP 300
13910 GLTPCVSTLV FNQTKDFCVM VQIVPRVYYY PEKVILDEYD YRNHRQKREP 299
15149 GLTPCVSTLV FNQTKDFCVM VQIVPRVYYY PEKVILDEYD YRNHRQKREP 299
13653 GLTPCVSTLV FNQTKDFCIM VQIVPRVYYY PEKAILDEYD YRNHRQKREP 300
15150 GLTPCVSTLV FNQTKDFCIM VQIVPRVYYY PEKAILDEYD YRNHRQKREP 300
PERV-C ISLTLAVMLG LGVAAGVGTG TAALVTGPQQ LETGLSNLHR IVTEDLQALE 332
PERV-A ISLTLAVMLG LGVAAGVGTG TAALITGPQQ LEKGLSNLHR IVTEDLQALE 350
13910 ISLTLAVMLG LGVAAGVGTG TAALVTGPQQ LEAGLSNLHR IVIEDLQALE 349
15149 ISLTLAVMLG LGVAAGVGTG TAALVTGPQQ LEAGLSNLHR IVIEDLQALE 349
13653 ISLTLAVMLG LGVAAGVGTG TAALVTGPQQ LETGLSNLHR IVTEDLQALE 350
15150 ISLTLAVMLG LGVAAGVGTG TAALVTGPQQ LETGLSNLHR IVTEDLQALE 350
PERV-C KSVSNLEESL TSLSEVVLQN RRGLDLLFLK EGGLCVALKE ECCFYVDHSG 382
PERV-A KSVSNLEESL TSLSEVVLQN RRGLDLLFLK EGGLCVALKE ECCFYVDHSG 400
13910 KSVSNLEESL TSLSEVVLQN RRGLDLLFLK EGGLCVALKE ECCFYVDHSG 399
15149   KSVSNLEESL TSLSEVVLQN RRGLDLLFLK EGGLCVALKE ECCFYVDHSG 399
13653 KSVSNLEESL TSLSEVVLQN RRGLDLLFLK EGGLCVALKE ECCFYVDHSG 400
15150 KSVSSLEESL TSLSEVVLQN RRGLDLLFLK EGGLCVALKE ECCFYVDHSG 400
PERV-C AIRDSMNKLR ERLEKRRREK ETTQGWFE     408
PERV-A AIRDSMSKLR ERLERRRRER EADQGWFE    426
13910 AIRDSMSKLR ERLEKRRREK ETTQGWFE 425
15149 AIRDSMSKLR ERLEKRRREK ETTQGWFE 425
13653 AIRDSMNKLR ERLEKRRREK ETTQGWFE 426
15150 AIRDSMNKLR ERLEKRRREK ETTQGWFE 426Virology Journal 2006, 3:91 http://www.virologyj.com/content/3/1/91
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The characterization of transmitting or non-transmitting
phenotypes may not be permanent. This idea is consistent
with the suggestion that the activity of PERV-C sites
"drives" the recombination process [5]. Further investiga-
tion is required to determine whether recombinant PERV
can be derived from proviral DNA sites as well as from
exogenous recombination of mRNA. In preliminary stud-
ies using stimulated PBMC from swine 15149 (transmit-
ter) and 16181 (non-transmitter), transmission assays
have not revealed infection of human 293 cells in vitro
over 110 days of cocultivation. While the levels of PERV
expression in these studies might be below the limit of
detection, it is possible that the two genomic PERV-AC
sequences detected here represent dysfunctional proviral
elements.
The presence of PERV-AC in the DNA of porcine tissues
from animals capable of transmitting infection to human
cells combined with the early coculture assays sited above,
suggest that the transmitting phenotype is intermittent. It
remains to be determined whether the transmitting phe-
notype is inherited or acquired de novo in swine. It
remains necessary to determine the conditions that deter-
mine the production of PERV-AC in vivo to determine the
level of risk for infection of human recipients of porcine
xenografts.
Materials and methods
Tissues were harvested from each animal, including
blood, heart, lung, thymus, pancreas, liver, kidney,
spleen, abdominal and thoracic lymph nodes, and skele-
tal muscle. Swine 15578, 15579, and 16181 were bred
with a deletion of the gene encoding alpha-1, 3-galactos-
yltransferase and are considered non-transmitters. Cell
samples from animal 12190 showed no transmission to
either human or porcine cells in vitro, designating it a
"null transmitter" [5]. Care of animals was in accordance
with the Guide for the Care and Use of Laboratory Ani-
mals prepared by the National Institutes of Health under
a protocol approved by the Massachusetts General Hospi-
tal Subcommittee on Research Animal Care.
Tissues were stored at -80°C. DNA was isolated using the
Puregene® DNA purification protocol (Gentra Systems,
Minneapolis, MN) per manufacturer's instructions. For
PCR amplification, PERV-A env  primer VRBF (forward)
(5'-CCTACCAGTTATAATCAATTTAATTATGGC-3') and
two different PERV-C env reverse primers were used: TMR
(5'-CTCAAACCACCCTTGAGTAGTTTCC-3') and PERV-C
reverse (5'-TATGTTAGAGGATGGTCCTGGTC-3') as previ-
ously described [5,12]. The presence of amplifiable por-
cine mitochondria cytochrome oxidase II was used as a
DNA quality control. Forward primer (5'-TCACCCAT-
CATAGAAGAACTCCTACA-3'), and reverse primer (5'-
TTTTACGGTTAAGGCTGGGTTATTAATT-3') were used to
amplify the mitochondrial DNA. Each PCR reaction
involved 100 ng of isolated DNA. All PERV reactions were
performed on a GeneAmp® PCR system 9700 (PE Applied
Biosystems, Foster City, CA) with the following parame-
ters: 94°C for 10 minutes, 40 cycles of 94°C for 30 sec-
onds, 55°C for 30 seconds, and 72°C for 120 seconds,
followed by 72°C for 10 minutes. For detection of porcine
mitochondrial markers, an annealing/melting tempera-
ture of 60°C was used.
Deduced PERV-AC amino acid sequence from 13910 shown in alignment with a PERV-A and PERV-C env sequence Figure 4
Deduced PERV-AC amino acid sequence from 13910 shown in alignment with a PERV-A and PERV-C env sequence. Sequences 
from both 13910 and 15149 were identical, hence only one representation shown. Blue amino acids represent PERV-A and red 
amino acids represent PERV-C. The sequences encoded by the forward PERV-A primer (VRBF) and reverse PERV-C primer 
(C-reverse) are underlined.
 PERV-C YTSSGQFNY- ---------- -LTWIRTGSP KCSPSDLDYL KISFTEKGKQ 38
 PERV-A PTSYNQFNYG HGRWKDWQQR VQKDVRNKQI SCHSLDLDYL KISFTEKGKQ 50
 PERV-AC PTSYNQFNYG HGRWKDWQQR VQKDVRNKQI SCHSLDLDYL KISFTEKGKQ 50
 PERV-C ENILKWVNGM SWGMVYYGGS GKQPGSILTI RLKIN-QLEP PMAIGPNTVL 87
PERV-A ENIQKWVNGI SWGIVYYGGS GRKKGSVLTI RLRIETQMEP PVAIGPNKGL 100
PERV-AC ENIQKWVNGM SWGIVYYGGS GRKKGSVLTI RLKIN-QLEP PMAIGPNTVL 100
PERV-C TGQRPPTQ-- --GPGPS-SN I 132
PERV-A AEQGPPIQEQ RPSPNPSDYN T 150
 PERV-AC TGQRPPTQ-- --GPGPS-SN I                                114Publish with BioMed Central    and   every 
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PCR products were isolated and cloned using the E. coli
plasmid vector pCR4-TOPO® or pCR-XL-TOPO® (Invitro-
gen, Carlsbad, CA) per the manufacturer's instructions.
Plasmids were isolated using QIAprep® Spin Miniprep col-
umns (Qiagen, Valencia, CA). Sequencing was done with
Applied Biosystems Taq DyeDeoxy Terminator cycle
sequencing kits on an ABI 3700 PRISM automated
sequencer (Massachusetts General Hospital DNA Core
Sequencing facility).
Coculture assays were done using viable PBMC from ani-
mals 15149 and 16181.
PBMC were stimulated for 5 days in phytohemagglutinin
and phorbol 12-myristate 13-acetate and then placed in
tissue culture flasks together with target human 293 cells.
Recombinant PERV-AC infection of human 293 cells was
assayed using the PCR methods noted above on harvested
cellular DNA from the human 293 cells on a once weekly,
to once every two week basis.
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